rs964184, ZPR1

N. diseases: 47
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
elevated blood glucose level
CUI: C0495706
Disease: elevated blood glucose level
111 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Eosinophil count procedure
CUI: C0200638
Disease: Eosinophil count procedure
1144 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2019 2019
Glucose measurement
CUI: C0337438
Disease: Glucose measurement
111 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Heart failure
CUI: C0018801
Disease: Heart failure
201 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Hematocrit procedure
CUI: C0018935
Disease: Hematocrit procedure
216 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Hyper LDL cholesterolaemia
CUI: C2242712
Disease: Hyper LDL cholesterolaemia
19 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.010 1.000 1 2015 2015
Hypochondroplasia (disorder)
CUI: C0410529
Disease: Hypochondroplasia (disorder)
42 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.010 1.000 1 2014 2014
Malignant neoplasm of prostate
CUI: C0376358
Disease: Malignant neoplasm of prostate
1082 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.010 1.000 1 2014 2014
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Metabolic Syndrome X
CUI: C0524620
Disease: Metabolic Syndrome X
591 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.810 1.000 1 2012 2012
Phospholipid measurement
CUI: C0202177
Disease: Phospholipid measurement
306 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.800 1.000 1 2012 2012
Platelet Component Distribution Width Measurement
200 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Platelet mean volume determination (procedure)
371 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Prostate carcinoma
CUI: C0600139
Disease: Prostate carcinoma
1168 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.010 1.000 1 2014 2014
Pseudocholinesterase Measurement
CUI: C1168443
Disease: Pseudocholinesterase Measurement
568 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2011 2011
Reticulocyte count (procedure)
CUI: C0206161
Disease: Reticulocyte count (procedure)
474 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Rheumatoid Arthritis
CUI: C0003873
Disease: Rheumatoid Arthritis
2387 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.010 1.000 1 2013 2013
Systolic Pressure
CUI: C0871470
Disease: Systolic Pressure
1931 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2016 2016
Vitamin E Assay
CUI: C1142098
Disease: Vitamin E Assay
4 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.800 1.000 1 2011 2011
Vitamin K Assay
CUI: C0042879
Disease: Vitamin K Assay
6 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2014 2014
Vitamin measurement
CUI: C0428580
Disease: Vitamin measurement
4 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2013 2013
VLDL cholesterol measurement
CUI: C0523560
Disease: VLDL cholesterol measurement
23 0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 0.700 1.000 1 2017 2017